✉news TechnologyTechnology first seen 1 d ago, last 1 d ago, peak #25
Rani Therapeutics Accepted into FDA Emerging Technology Program
Original: Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
Rani Therapeutics says the U.S. FDA has accepted the company into its Emerging Technology Program, which gives participants early, regular engagement with the agency on innovative manufacturing and product technologies. Acceptance can help the company advance its oral delivery platform through development and regulatory review, and investors and industry watchers are noting the regulatory endorsement.
Why now: FDA program acceptance is a notable regulatory milestone for a clinical-stage medtech company, drawing investor and industry attention.
Rani TherapeuticsU.S. Food and Drug AdministrationEmerging Technology Program
Evidence
- Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP) · Yahoo! Finance Canada
API: https://socialmediatrends-api.osmike.com/v1/trends/1114976